100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4.6 TrustPilot
logo-home
Exam (elaborations)

TEST BANK PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBERS 6TH EDITION | Chapter 1-57 | Fully covered

Rating
-
Sold
-
Pages
216
Grade
A+
Uploaded on
04-07-2025
Written in
2024/2025

TEST BANK PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBERS 6TH EDITION | Chapter 1-57 | Fully covered

Institution
Pharmacotherapeutics For Advanced Nursing Practice
Course
Pharmacotherapeutics For Advanced Nursing Practice











Whoops! We can’t load your doc right now. Try again or contact support.

Written for

Institution
Pharmacotherapeutics For Advanced Nursing Practice
Course
Pharmacotherapeutics For Advanced Nursing Practice

Document information

Uploaded on
July 4, 2025
Number of pages
216
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers

Subjects

Content preview

TESTBANK
PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE |! |! |! |! |!



PRESCRIBERS,6TH EDITION
|! A


Author: Teri Moser Woo and Wendy L. Wright
|! |! |! |! |! |! |!

, TABLE OF CONTENT |! |!




Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ......................................................... 4
|! |! |! |! |! |! |! |! |! |!



Chapter 2. Review of Basic Principles of Pharmacology ........................................................................... 5
|! |! |! |! |! |! |!



Chapter |! 3. |! Rational Drug Selection ............................................................................................................ 11
|! |!



Chapter |! 4. |! Legal and Professional Issues in Prescribing .......................................................................... 14
|! |! |! |! |!



Chapter |! 5. |! Adverse Drug Reactions ........................................................................................................... 16
|! |!



Chapter |! 6. |! An Introduction to Pharmacogenomics..................................................................................... 19
|! |! |!



Chapter |! 7. |! Nutrition and Nutraceuticals ..................................................................................................... 22
|! |!



Chapter |! 8. Herbal Therapies ........................................................................................................................ 28
|! |!



Chapter |! 9. Cannabis ..................................................................................................................................... 31
|!



Chapter |! 10. Pharmacoeconomics .................................................................................................................. 35
|!



Chapter |! 11. Drugs Affecting the Autonomic Nervous System ................................................................. 38
|! |! |! |! |! |!



Chapter |! 12. |! Drugs |! Affecting |! the |! Central Nervous System ....................................................................... 45
|! |!



Chapter |! 13. |! Drugs |! Affecting |! the |! Cardiovascular and Renal Systems ...................................................... 53
|! |! |!



Chapter |! 14. |! Drugs |! Affecting |! the |! Respiratory System ............................................................................... 61
|!



Chapter |! 15. |! Drugs |! Affecting |! the |! Hematological System ........................................................................... 65
|!



Chapter |! 16. |! Drugs |! Affecting |! the |! Immune System: Vaccines and Immunoglobulins ............................... 69
|! |! |! |!



Chapter 17. Drugs Affecting the Immune System: Immunomodulators.................................................... 75
|! |! |! |! |! |! |!



Chapter 18. Drugs Affecting the Gastrointestinal System ......................................................................... 77
|! |! |! |! |! |!



Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ......... 80
|! |! |! |! |! |! |! |! |! |! |!



Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................ 83
|! |! |! |! |! |! |! |! |! |! |!



Chapter |! 21. |! Drugs |! Affecting the Reproductive System ............................................................................. 86
|! |! |!



Chapter |! 22. |! Drugs |! Affecting the Bones and Joints .................................................................................. 92
|! |! |! |!



Chapter |! 23. |! Drugs |! Affecting the Integumentary System ........................................................................... 96
|! |! |!



Chapter |! 24. |! Drugs |! Used to Treat Bacterial Infections............................................................................ 101
|! |! |! |!



Chapter |! 25. |! Drugs |! Used to Treat Viral, Fungal, and Protozoal Infections ........................................... 105
|! |! |! |! |! |! |!



Chapter |! 26. |! Drugs Used to Treat Inflammatory Processes ..................................................................... 108
|! |! |! |! |!



Chapter |! 27. |! Drugs Used to Treat Eye and Ear Disorders ..................................................................... 111
|! |! |! |! |! |! |!



Chapter |! 28. |! Anemia ................................................................................................................................... 113
Chapter |! 29. |! Anxiety and Depression ........................................................................................................ 116
|! |!



Chapter 30. Attention Deficit-Hyperactivity Disorder............................................................................... 120
|! |! |! |!



Chapter |! 31. |! Asthma and Allergy .............................................................................................................. 122
|! |!



Chapter |! 32. |! Chronic Obstructive Pulmonary Disease............................................................................... 125
|! |! |!



Chapter |! 33. |! Contraception.......................................................................................................................... 127
Chapter |! 34. |! COVID-19: Acute and Chronic ............................................................................................ 130
|! |! |!



Chapter |! 35. |! Dermatological Conditions ..................................................................................................... 134
|!



Chapter |! 36. |! Diabetes Management ............................................................................................................ 138
|!



Chapter |! 37. |! Gastroesophageal Reflux and Peptic Ulcer Disease ............................................................ 146
|! |! |! |! |!



Chapter |! 38. |! Headaches ............................................................................................................................... 149
Chapter 39. Heart Failure .......................................................................................................................... 153
|! |! |!



Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ................................................... 158
|! |! |! |! |! |! |!



Chapter 41. Menopausal Hormone Therapy ............................................................................................. 161
|! |! |! |!

,Chapter 42. Hyperlipidemia ....................................................................................................................... 164
|! |!



Chapter |! 43. |! Hypertension ........................................................................................................................... 169
Chapter |! 44. |! Hyperthyroidism and Hypothyroidism .................................................................................. 174
|! |!



Chapter |! 45. |! Obesity ................................................................................................................................... 177
Chapter |! 46. |! Pain Management: Acute and Chronic Pain ....................................................................... 181
|! |! |! |! |!



Chapter 47. Pneumonia .............................................................................................................................. 185
|! |!



Chapter 48. Sexually Transmitted Diseases and Vaginitis ....................................................................... 187
|! |! |! |! |! |!



Chapter 49. Substance Use Disorders ....................................................................................................... 190
|! |! |! |!



Chapter 50. Tuberculosis ............................................................................................................................ 195
|! |!



Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa 197
|! |! |! |! |! |! |! |! |! |! |! |!



Chapter |! 52. |! Urinary Tract Infections ........................................................................................................ 200
|! |!



Chapter |! 53. |! Women as Patients ................................................................................................................ 203
|! |!



Chapter |! 54. |! Men as Patients ..................................................................................................................... 207
|! |!



Chapter |! 55. |! Pediatric Patients .................................................................................................................... 209
|!



Chapter 57. Geriatric Patients .................................................................................................................... 213
|! |! |!

, Woo 1
Pharmacotherapeutics for APN Prescribers, |! |! |! |! Ch01
6e

Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
|! |! |! |! |! |! |! |! |! |!




MULTIPLE CHOICE |!




1. Nurse practitioner prescriptive authority is regulated by:
|! |! |! |! |! |!


A. The National Council of State Boards of Nursing
|! |! |! |! |! |! |!


B. The U.S. Drug Enforcement Administration
|! |! |! |!


C. The State Board of Nursing for each state
|! |! |! |! |! |! |!


D. The State Board of Pharmacy
|! |! |! |!




ANS: | ! C PTS: 1

2. The benefits to the patient of having an advanced practice registered nurse (APRN)
|! |! |! |! |! |! |! |! |! |! |! |! |!


prescrib er include:
|! |!


A. Nurses know more about pharmacology than other prescribers because they
|! |! |! |! |! |! |! |! |! |!


take it both in their basic nursing program and in their APRN program.
|! |! |! |! |! |! |! |! |! |! |! |!


B. Nurses care for the patient from a holistic approach and include the
|! |! |! |! |! |! |! |! |! |! |! |!


patient i n decision-making regarding their care.
|! |! |! |! |! |!


C. APRNs are less likely to prescribe narcotics and other controlled substances.
|! |! |! |! |! |! |! |! |! |!


D. APRNs are able to prescribe independently in all states, whereas a
|! |! |! |! |! |! |! |! |! |! |!


physician’ s assistant needs to have a physician supervising their practice.
|! |! |! |! |! |! |! |! |! |!




ANS: | ! B PTS: 1

3. Clinical judgment in prescribing includes:
|! |! |! |!


A. Factoring in the cost to the patient of the medication prescribed
|! |! |! |! |! |! |! |! |! |!


B. Always prescribing the newest medication available for the disease process
|! |! |! |! |! |! |! |! |!


C. Handing out drug samples to poor patients |! |! |! |! |! |!


D. Prescribing all generic medications to cut costs |! |! |! |! |! |!




ANS: | ! A PTS: 1

4. The process for choosing an effective drug for a disorder includes:
|! |! |! |! |! |! |! |! |! |!


A. Asking the patient what drug they think would work best for them
|! |! |! |! |! |! |! |! |! |! |!


B. Consulting nationally recognized guidelines for disease management
|! |! |! |! |! |!


C. Prescribing medications that are available as samples before writing a prescription
|! |! |! |! |! |! |! |! |! |!


D. Following U.S. Drug Enforcement Administration guidelines for prescribing
|! |! |! |! |! |! |!




ANS: | ! B PTS: 1

5. Nonintentional nonadherence of drug therapy may occur due to: |! |! |! |! |! |! |! |!


A. Belief that medication does not work
|! |! |! |! |!


B. Adverse drug reactions |! |!


C. Chronic conditions that require daily therapy
|! |! |! |! |!


D. Forgetfulness or distraction |! |!




ANS: | ! D PTS: 1

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
Ruiz Liberty University
View profile
Follow You need to be logged in order to follow users or courses
Sold
82
Member since
1 year
Number of followers
1
Documents
12142
Last sold
11 hours ago
Top-Quality Study Materials for Success – Ace Your Exams with Expert Resources!

Access high-quality study materials to help you excel in your exams. Get notes, summaries, and guides tailored to your courses!

3.2

9 reviews

5
3
4
1
3
2
2
1
1
2

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions